Skip to main content
Top
Published in: Pediatric Surgery International 9-10/2003

01-11-2003 | Original Article

Relapses in Wilms tumour

Author: Carl-Magnus Kullendorff

Published in: Pediatric Surgery International | Issue 9-10/2003

Login to get access

Abstract

During an 18-year period, 54 children were treated for Wilms tumour (WT). Thirteen of them, 6 boys and 7 girls, had a relapse. Mean age at diagnosis was 50 months, range 5–233 months. The investigations revealed stage I in 5 cases, stage II in 2, stage III in 3, stage IV in 1 and stage V in 2.The histology was favourable in 6 cases, intermediate in 4 and unfavourable in 3. Clonal chromosome aberrations were detected in 8 cases. The mean time to first relapse was 17 months, range 1–76 months. The location was the local region in 3 cases, other kidney in 3, lungs in 7 and skeletal in 2. A second relapse occurred in 6 patients and a third relapse in 2 patients. Seven patients died after a mean follow-up of 84 months, range 42–180 months, from primary treatment. The 6 surviving children had no evidence of disease after a mean follow-up of 70 months, range 42–120 months, after treatment ended. High stage at diagnosis, unfavourable histologic subtype and occurrence of nephroblastomatosis were found not only in the children with relapse. No significant correlations were found when comparing the karyotypic features with clinical outcome. All 3 tumours with deletions of chromosome arm 16q metastasized.
Literature
1.
go back to reference Abu-Ghosh AM, Krailo MD, Goldman SC, Slack RS, Davenport V, Morris E, Laver JH, Reaman GH, Cairo MS (2002) Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms’ tumor: a Children’s Cancer Group report. Ann Oncol 13:460–469CrossRefPubMed Abu-Ghosh AM, Krailo MD, Goldman SC, Slack RS, Davenport V, Morris E, Laver JH, Reaman GH, Cairo MS (2002) Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms’ tumor: a Children’s Cancer Group report. Ann Oncol 13:460–469CrossRefPubMed
2.
go back to reference Bergeron C, Iliescu C, Thiesse P, Bouvier R, Dijour F, Ranchere-Vince D, Basset T, Chappius JP, Buclon M, Frappaz D, Brunat-Mentigny M, Philip T (2001) Does nephroblastomatosis influence the natural history and relapse rate in Wilms’ tumour? A single centre experience over 11 years. Eur J Cancer 37:385–391CrossRefPubMed Bergeron C, Iliescu C, Thiesse P, Bouvier R, Dijour F, Ranchere-Vince D, Basset T, Chappius JP, Buclon M, Frappaz D, Brunat-Mentigny M, Philip T (2001) Does nephroblastomatosis influence the natural history and relapse rate in Wilms’ tumour? A single centre experience over 11 years. Eur J Cancer 37:385–391CrossRefPubMed
3.
go back to reference Bown N, Cotterill SJ, Roberts P, Griffiths M, Larkins S, Hibbert S, Middleton H, Kelsey A, Tritton D, Mitchell C (2001) Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. cancer cytogenetics group and the U.K. Children’s Cancer Study Group. Med Pediatr Oncol 38:11–21CrossRef Bown N, Cotterill SJ, Roberts P, Griffiths M, Larkins S, Hibbert S, Middleton H, Kelsey A, Tritton D, Mitchell C (2001) Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. cancer cytogenetics group and the U.K. Children’s Cancer Study Group. Med Pediatr Oncol 38:11–21CrossRef
4.
go back to reference Daw NC, Kauffman WM, Bodner SM, Pratt CB, Hoffer FA (2002) Patterns of abdominal relapse and role of sonography in Wilms tumor. Pediatr Hematol Oncol 19:107–115CrossRefPubMed Daw NC, Kauffman WM, Bodner SM, Pratt CB, Hoffer FA (2002) Patterns of abdominal relapse and role of sonography in Wilms tumor. Pediatr Hematol Oncol 19:107–115CrossRefPubMed
5.
go back to reference Dome JS, Liu T, Krasin M, Lott L, Shearer P, Daw NC, Billups CA, Wilimas JA (2002) Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children’s Research Hospital. J Pediatr Hematol Oncol 24:192–198CrossRefPubMed Dome JS, Liu T, Krasin M, Lott L, Shearer P, Daw NC, Billups CA, Wilimas JA (2002) Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children’s Research Hospital. J Pediatr Hematol Oncol 24:192–198CrossRefPubMed
6.
go back to reference Grundy P, Telzerow P, Moksness J, Breslow NE (1996) Clinicopathologic correlates of loss of heterozygosity in Wilms’ tumor: a preliminary analysis. Med Pediatr Oncol 27:429–433CrossRefPubMed Grundy P, Telzerow P, Moksness J, Breslow NE (1996) Clinicopathologic correlates of loss of heterozygosity in Wilms’ tumor: a preliminary analysis. Med Pediatr Oncol 27:429–433CrossRefPubMed
7.
go back to reference Grundy RG, Pritchard J, Scambler P, Cowell JK (1998) Loss of heterozygosity on chromosome 16 in sporadic Wilms’ tumour. Br J Cancer 78:1181–1187PubMed Grundy RG, Pritchard J, Scambler P, Cowell JK (1998) Loss of heterozygosity on chromosome 16 in sporadic Wilms’ tumour. Br J Cancer 78:1181–1187PubMed
8.
go back to reference Hing L, Lu YJ, Summersgill B, King-Underwood L, Nicholson J, Grundy P, Grundy R, Gessler M, Shipley J, Pritchard-Jones K (2001) Gain of 1q is associated with adverse outcome in favourable histology Wilms’ tumors. Am J Pathol 158:393–398PubMed Hing L, Lu YJ, Summersgill B, King-Underwood L, Nicholson J, Grundy P, Grundy R, Gessler M, Shipley J, Pritchard-Jones K (2001) Gain of 1q is associated with adverse outcome in favourable histology Wilms’ tumors. Am J Pathol 158:393–398PubMed
9.
go back to reference Klamt B, Schulze M, Thäte C (1998) Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlates with clinicopathologic parameters. Genes Chromosomes Cancer 22:287–294CrossRefPubMed Klamt B, Schulze M, Thäte C (1998) Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlates with clinicopathologic parameters. Genes Chromosomes Cancer 22:287–294CrossRefPubMed
10.
go back to reference de Kraker J, Graf N, Pein F, van Tinteren H, Sandstedt B, Godzinski J (2002) The SIOP Nephroblastoma Study 9301 two years after closure for randomisation—an update. Med Pediatr Oncol 39:235 de Kraker J, Graf N, Pein F, van Tinteren H, Sandstedt B, Godzinski J (2002) The SIOP Nephroblastoma Study 9301 two years after closure for randomisation—an update. Med Pediatr Oncol 39:235
11.
go back to reference Kullendorff CM, Soller M, Wiebe T, Mertens F (2003) Cytogenetic findings and clinical course in a consecutive series of Wilms’ tumors. Cancer Genet Cytogenet 140:82–87 Kullendorff CM, Soller M, Wiebe T, Mertens F (2003) Cytogenetic findings and clinical course in a consecutive series of Wilms’ tumors. Cancer Genet Cytogenet 140:82–87
12.
go back to reference Miser S, Tournade MF (1995) The management of relapsed Wilms tumor. Hematol Oncol Clin North Am 9:1287–1302PubMed Miser S, Tournade MF (1995) The management of relapsed Wilms tumor. Hematol Oncol Clin North Am 9:1287–1302PubMed
13.
go back to reference Misra D, Gupta DK, Mitra DK, Bhatnagar V, Bajpai M, Mathur M, Rohatgi M (1996) Management of metastatic Wilms tumor: an eleven year experience. Indian J Cancer 33:1–5PubMed Misra D, Gupta DK, Mitra DK, Bhatnagar V, Bajpai M, Mathur M, Rohatgi M (1996) Management of metastatic Wilms tumor: an eleven year experience. Indian J Cancer 33:1–5PubMed
14.
go back to reference Shamberger RC, Guthrie KA, Ritchey ML, Haase GM, Takashima J, Beckwith JB, D’Angio GJ, Green DM, Breslow NE (1999) Surgery-related factors and local recurrence of Wilms tumor in national Wilms tumor study 4. Ann Surg 229:292–297CrossRefPubMed Shamberger RC, Guthrie KA, Ritchey ML, Haase GM, Takashima J, Beckwith JB, D’Angio GJ, Green DM, Breslow NE (1999) Surgery-related factors and local recurrence of Wilms tumor in national Wilms tumor study 4. Ann Surg 229:292–297CrossRefPubMed
15.
go back to reference Skotnicka-Klonowicz G, Rieske P (2000) 16q heterozygosity loss in Wilms’ tumour in children and its clinical importance. Eur J Surg Oncol 26:61–66CrossRefPubMed Skotnicka-Klonowicz G, Rieske P (2000) 16q heterozygosity loss in Wilms’ tumour in children and its clinical importance. Eur J Surg Oncol 26:61–66CrossRefPubMed
Metadata
Title
Relapses in Wilms tumour
Author
Carl-Magnus Kullendorff
Publication date
01-11-2003
Publisher
Springer-Verlag
Published in
Pediatric Surgery International / Issue 9-10/2003
Print ISSN: 0179-0358
Electronic ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-003-0982-9

Other articles of this Issue 9-10/2003

Pediatric Surgery International 9-10/2003 Go to the issue